Quantbot Technologies LP Phathom Pharmaceuticals, Inc. Transaction History

Quantbot Technologies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$9.18 - $11.53 $3,672 - $4,612	-400 Reduced 12.02%	2,927 $32,000
Q3 2022 Nov 07, 2022	SELL	$6.46 - $12.11 $14,212 - $26,642	-2,200 Reduced 39.8%	3,327 $36,000
Q2 2022 Aug 09, 2022	BUY	$6.2 - $15.5 $18,147 - $45,368	2,927 Added 112.58%	5,527 $46,000
Q1 2022 May 16, 2022	SELL	$11.55 - $20.06 $2,310 - $4,011	-200 Reduced 7.14%	2,600 $35,000
Q4 2021 Feb 11, 2022	BUY	$17.83 - $33.15 $32,093 - $59,670	1,800 Added 180.0%	2,800 $55,000
Q3 2021 Nov 09, 2021	BUY	$30.69 - $36.83 $30,690 - $36,830	1,000 New	1,000 $32,000

157

68.4M

52.3K

635K

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $257M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.